JAZZ vs TYL · P/E 1988, rev $2.28B vs P/E 89, rev $1.26B
Jazz Pharmaceuticals PLC (JAZZ) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the JAZZ and TYL stock pages for the full models.
Not investment advice.